10rx vs Fierce Health
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
10rx
Best for budget-focused patients who want low-cost compounded GLP-1 with NAD+ and sermorelin add-onsStarting at $99.67/mo
Fierce Health
Best for compounded GLP-1 with standard and microdose protocols plus a longevity catalogStarting at $/mo
Side-by-Side Comparison
| Feature | 10rx | Fierce Health |
|---|---|---|
| Overall Score | ✓7.0/10 | 6.9/10 |
| Starting Price | $99.67/mo | $/mo |
| Editorial Rating | 3.5 ★ /5 | 3.5 ★ /5 |
| Features | ✓8 features | 5 features |
| States Available | 0 | ✓30 |
| Compounded | — | — |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | ✓None | 5 warnings |
Pros & Cons
10rx
What we like
- Very low pricing — compounded semaglutide $99.67/month and tirzepatide $149.67/month
- Free online health quiz with board-certified telehealth doctors reviewing eligibility
- Offers NAD+ and sermorelin alongside GLP-1, for energy and muscle recovery
- Says it ships to all 50 states with discreet delivery from licensed pharmacy partners
Watch-outs
- Doesn't publish its legal operating entity, so accountability is hard to verify
- Pharmacy partners are described as licensed but none are named
- No terms-of-service page is posted, and FAQ answers load only via script
- Compounded semaglutide and tirzepatide only — no brand-name or oral options
- No LegitScript or third-party accreditation is shown on the site
Fierce Health
What we like
- 30-state service list spelled out in the Terms — buyers can verify eligibility before intake
- LegitScript Certified
- Publishes the FDA compounded-medication disclaimer on every product page
- Four GLP-1 programs (standard and microdose semaglutide and tirzepatide) — a broader ladder than peers
- Microdose tier at $197/mo is one of the lower entry points we've seen
- Explicit refund policy if they can't ship to your state
- Monthly, 3-month, and 6-month subscription options
Watch-outs
- No named 503A compounding pharmacy partner — only generic 'partner pharmacies' language
- Operating LLC name not disclosed anywhere on the site
- Tirzepatide weight-loss program ($497/mo) showing 'sold out or unavailable' across all plans at review time
- Clinical provider network not named
- Sells gray-market longevity products (ivermectin, methylene blue) alongside GLP-1s — an unusual category mix
- Only LegitScript — no PCAB, BBB, or NABP .pharmacy presence
- Tirzepatide tier at $497/mo is at the high end of the segment
- Compounded semaglutide and tirzepatide are not FDA-approved
Our Verdict
10rx edges out Fierce Health with a higher overall score of 7.0/10 and is particularly strong for budget-focused patients who want low-cost compounded GLP-1 with NAD+ and sermorelin add-ons. Fierce Health remains a solid alternative, especially if you're looking for compounded GLP-1 with standard and microdose protocols plus a longevity catalog.
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Related comparisons
Continue exploring 10rx and Fierce Health head-to-heads in the same category.
- 10rx vs CoreAge Rx
- 10rx vs TrimRx
- 10rx vs Amazon One Medical
- Fierce Health vs NovoCare Pharmacy
- Fierce Health vs Vytora Health
- Fierce Health vs Enhance MD
Or see the full category ranking.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.